What is SQZ Biotechnologies Co Cash, Cash Equivalents, Marketable Securities?
SQZ Biotechnologies Co's quarterly cash, cash equivalents, marketable securities
declined
from Mar. 2023 ($39.87 Mil) to Jun. 2023 ($24.71 Mil) but then
stayed the same
from Jun. 2023 ($24.71 Mil) to Sep. 2023 ($10.19 Mil).
SQZ Biotechnologies Co's annual cash, cash equivalents, marketable securities
declined
from Dec. 2020 ($170.36 Mil) to Dec. 2021 ($143.51 Mil) and
declined
from Dec. 2021 ($143.51 Mil) to Dec. 2022 ($63.71 Mil).
SQZ Biotechnologies Co Cash, Cash Equivalents, Marketable Securities Historical Data
The historical data trend for SQZ Biotechnologies Co's Cash, Cash Equivalents, Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
SQZ Biotechnologies Co Cash, Cash Equivalents, Marketable Securities Chart
SQZ Biotechnologies Co Cash, Cash Equivalents, Marketable Securities Calculation
Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.
SQZ Biotechnologies Co (OTCPK:SQZB) Cash, Cash Equivalents, Marketable Securities Explanation
Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
A high number means either:
1) The company has competitive advantage generating lots of cash
2) Just sold a business or bonds (not necessarily good)
A low stockpile of cash usually means poor to mediocre economics.
There are 3 ways to create large cash reserve.
1) Sell new bonds or equity to public
2) Sell business or asset
3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)
When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.
Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.
Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.
SQZ Biotechnologies Co Cash, Cash Equivalents, Marketable Securities Related Terms
Thank you for viewing the detailed overview of SQZ Biotechnologies Co's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.
SQZ Biotechnologies Co (SQZ Biotechnologies Co) Business Description
SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability to deliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SQZB has been successfully added to your 